Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA
Completed
Jazz Pharmaceuticals
Phase 2
2016-07-05
This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the
effect of JZP-110 on driving performance in subjects with excessive sleepiness due to
obstructive sleep apnea.
Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
Completed
Jazz Pharmaceuticals
Phase 2
2016-06-01
This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the
effect of JZP-110 on driving performance in subjects with excessive sleepiness due to
narcolepsy.
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
Recruiting
National Cancer Institute (NCI)
Phase 2
2021-01-27
This phase II trial studies the side effects of solriamfetol in improving sleep in patients
with grade II-IV glioma. Solriamfetol is a wakefulness-promoting drug. Giving solriamfetol
may improve sleep, memory, fatigue, mood, or quality of life in patients with brain tumors
(gliomas).
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
Recruiting
Wake Forest University Health Sciences
Phase 2
2021-01-27
This phase II trial studies the side effects of solriamfetol in improving sleep in patients
with grade II-IV glioma. Solriamfetol is a wakefulness-promoting drug. Giving solriamfetol
may improve sleep, memory, fatigue, mood, or quality of life in patients with brain tumors
(gliomas).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
